European Joint Actions

HPRA representatives contribute to a number of EU Joint Actions. Joint Actions are collaborative projects funded and coordinated at EU level, primarily under the EU4Health Programme, in which EU Member States and associated countries work together to address shared public health priorities.

The initiatives listed below are funded by the European Union.

IncreaseNET

Supporting the increased capacity and competence building of the EU medicines regulatory network 

IncreaseNET is an initiative to strengthen the EU medicines regulatory network by boosting the skills and capacity of national medicines agencies. It aims to improve medicines assessment and enhance access to innovative, high‑quality, effective and safe treatments. The initiative involves 29 organisations from the EU and Ukraine. The HPRA leads Work Package 5, focusing on the development of training materials.

To learn more, visit the IncreaseNET webpage.

Chessmen

Coordination and Harmonisation of the Existing Systems against Shortages of Medicines – European Network

CHESSMEN  aims to strengthen Europe’s ability to prevent, monitor, and manage medicine shortages. The HPRA leads Work Package 4, which is responsible for ensuing the sustainability of the identified policy measures, including good practices.

To learn more, visit the CHESSMEN website.

JAMS 2.0

Joint Action on Reinforced Market Surveillance for Medical Devices and In Vitro Medical Devices

JAMS 2.0 aims to strengthen and harmonise the market surveillance of medical devices and in vitro diagnostics through joint inspections, signal‑detection activities, surveillance campaigns, and shared training resources, ultimately improving regulatory coordination and ensuring devices on the EU market are safe and compliant.

To learn more, see the JAMS 2.0 - CAMD webpage. 

GAAP-PRO

Piloting GAPP model approach for assessing and authorising novel substances of human origin preparation PROcesses

GAAP‑PRO  focuses on harmonising how EU Member States assess and authorise preparation processes for blood, tissues, cells, and other substances of human origin. It also aims to help implement the new EU SoHO Regulation making the process more consistent and efficient across Europe. 

To learn more, visit the GAPP-PRO webpage.

European Union funding

The initiatives listed above are funded by the European Commission.